New York Life Investment Management’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $596K | Buy |
45,682
+3,291
| +8% | +$42.9K | 0.01% | 740 |
|
|
2025
Q1 | $631K | Buy |
+42,391
| New | +$631K | 0.01% | 742 |
|
|
2024
Q2 | – | Sell |
-19,348
| Closed | -$362K | – | 940 |
|
|
2024
Q1 | $362K | Buy |
19,348
+3,875
| +25% | +$72.5K | ﹤0.01% | 1160 |
|
|
2023
Q4 | $350K | Sell |
15,473
-454
| -3% | -$10.3K | ﹤0.01% | 1113 |
|
|
2023
Q3 | $395K | Sell |
15,927
-2,538
| -14% | -$62.9K | ﹤0.01% | 885 |
|
|
2023
Q2 | $518K | Sell |
18,465
-1,907
| -9% | -$53.5K | 0.01% | 695 |
|
|
2023
Q1 | $455K | Sell |
20,372
-5,807
| -22% | -$130K | 0.01% | 1136 |
|
|
2022
Q4 | $696K | Buy |
26,179
+2,810
| +12% | +$74.7K | 0.01% | 685 |
|
|
2022
Q3 | $663K | Buy |
23,369
+1,849
| +9% | +$52.5K | 0.01% | 660 |
|
|
2022
Q2 | $448K | Buy |
+21,520
| New | +$448K | 0.01% | 793 |
|